Navigation Links
Ghengis Khan wonder berry could conquer heart disease

Berries taken since the time of Ghengis Khan could form the basis of the next big thing in heart health. Sea buckthorn is a known source of biologically active chemicals and is used in Tibet, Mongolia, China and Russia for health drinks and various cosmetics. Juice extracted using current methods is of poor quality, but scientists in India have developed a highly efficient technique to extract large quantities of cholesterol-lowering compounds. Two companies have shown interest in the process including one based in Mongolia.

In research due to be published this week in SCI's Journal of the Science of Food and Agriculture (DOI 10.1002/jsfa2620) Dr C Arumyghan and his team at the Regional Research Laboratory, Trivandrum report the implementation of a new process which retains more than 40% of polyphenols - the same beneficial chemicals found in red wine, 50% of flavonoids and 70% of vitamin C present in the pulp of the red berries.

Antioxidants in the berries inhibit so-called 'bad' LDL cholesterol oxidisation, which could provide a new weapon to fight cardiovascular disease. When LDL cholesterol is oxidized, it sticks to the lining of blood vessels. Consuming the berries in food or drinks is expected to prevent the arteries from clogging up.

Arumughan is confident that this technology had great potential, saying "No previous report has shown efficiency matching ours". Arumughan's team have unlocked the nutrients by applying novel processing technique for the first time. The key to their success is using continuous high speed centrifugation (spinning) to separate the juice and the solid sludge.
'"/>

Source:Society of Chemical Industry


Page: 1

Related biology news :

1. Give thanks for the cranberry, say dental researchers
2. Strawberry daiquiris -- the extra-healthy cocktail?
3. Protein discovery could unlock the secret to better TB treatment
4. Tiny particles could solve billion-dollar problem
5. First atlas of key brain genes could speed research on cancer, neurological diseases
6. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
7. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
8. How the environment could be damaging mens reproductive health
9. Dead zone area in Gulf could be increasing, researchers say
10. Growth in biomass could put US on road to energy independence
11. Nano-bumps could help repair clogged blood vessels
Post Your Comments:
(Date:12/14/2009)... you are spending the holidays with big Uncle Frank ... be better off with another family, spare a thought ... team from McMaster University and the University of New ... that lives in groups, members make strategic decisions about ... the current issue of Biology Letters . , ...
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... Yale University researchers has used nanosensors to measure ... time. Their findings, which appear December 13 in ... , could dramatically simplify the way physicians test ... , The teamled by Mark Reed, Yale,s ... and Tarek Fahmy, an associate professor of biomedical ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Private Care Association of Floridas Elects Jim Mark as Vice President 58579 1Private Care Association of Floridas Elects Jim Mark as Vice President 58579 2Biotel Announces Fourth Quarter and Year End Results 14304 1Biotel Announces Fourth Quarter and Year End Results 14304 2Study Debunks Link Between Strep and Brain Disorders 58574 1Study Debunks Link Between Strep and Brain Disorders 58574 2
... birds took to the skies by gliding from trees ... according to new research by a University of Calgary ... Department of Biological Sciences PhD student Nick Longrich challenges ... from the ground while running and shows that the ...
... first large, single-institution series directly comparing weight-loss outcomes ... Chicago found that a newer operation, the duodenal ... standard operation, the Roux-en-Y gastric bypass. , In ... the researchers report that the duodenal switch (DS) ...
... from tennis elbow may not have to look any ... most effective treatment, according to a study published in ... Medicine. , Specially-prepared platelets taken from the patient which ... elbow provides more relief than more commonly-used therapies which ...
Other Biology News:Ancient birds flew on all-fours 2For super-obese patients, duodenal switch beats gastric bypass 2For super-obese patients, duodenal switch beats gastric bypass 3New biologic treatment for tennis elbow may replace surgery for chronic sufferers 2New biologic treatment for tennis elbow may replace surgery for chronic sufferers 3
(Date:12/15/2009)... has announced the launch of several innovative new programs ... in the current economic climate. The first is ... finance legal services over a period of 6, 12, ... their start-up companies. The second is aimed at ... arrangements over 6 to 12 month period at discounted ...
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... Joins with State Biotech Leaders to Develop ... and Development while Boosting Rhode Island,s Growing ... PROVIDENCE, R.I., Dec. 14 Several ... research, medicine and biotechnology gathered today at ... the importance of medical innovation in Rhode ...
(Date:12/14/2009)... Mass., Dec. 14 Boston Scientific Corporation (NYSE: ... a public offering of $2 billion aggregate principal amount ... statement. The public offering consists of $850 million ... of 6.00 percent notes due January 2020 and $300 ... Boston Scientific plans to use the net proceeds for ...
Breaking Biology Technology:The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3
... RainDance Technologies will,present a workshop titled ... Society of Human Genetics (ASHG) 58th Annual,Meeting ... Recent advances in DNA sequencing technologies have ... with the improved efficiency,of "second generation" systems, ...
... 3 Arno Therapeutics,Inc. (OTC Bulletin Board: ARNI), a ... Dr. Roger G. Berlin,Chief Executive Officer of Arno, will ... on Monday, November 10, 2008 at 2:00 PM EST ... Hotel in New York City. Dr.,Berlin will provide a ...
... Mass., Nov. 3 Verenium Corporation,(Nasdaq: VRNM ... cellulosic,ethanol and high-performance specialty enzymes, announced today that ... Monday, November 10,2008 after market close. In conjunction ... call with live webcast on Monday, November 10 ...
Other Biology Technology:RainDance Technologies to Present 'Sequence Enrichment Using Droplet-Based Microfluidics' Workshop at ASHG 2008 2Arno Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 2Verenium Corporation to Announce Third Quarter 2008 Financial Results 2Verenium Corporation to Announce Third Quarter 2008 Financial Results 3
Request Info...
Amyloid stain....
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Biology Products: